Sankar N. Sanyal - Publications

Selenium-Based Novel Epigenetic Regulators Offer Effective Chemotherapeutic Alternative with Wider Safety Margins in Experimental Colorectal Cancer.

Journal: Biological trace element research

Published: December 30, 2020

Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling.

Journal: Cellular signalling

Published: July 14, 2020

Imatinib modulates pro-inflammatory microenvironment with angiostatic effects in experimental lung carcinogenesis.

Journal: Inflammopharmacology

Published: August 31, 2019

Chemopreventive action of Imatinib, a tyrosine kinase inhibitor in the regulation of angiogenesis and apoptosis in rat model of lung cancer.

Journal: Molecular and cellular biochemistry

Published: September 06, 2017

Chemoprevention of Colon Cancer through Inhibition of Angiogenesis and Induction of Apoptosis by Nonsteroidal Anti-Inflammatory Drugs.

Journal: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer

Published: December 03, 2016

Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 12, 2015

Cell cycle regulation and apoptotic cell death in experimental colon carcinogenesis: intervening with cyclooxygenase-2 inhibitors.

Journal: Nutrition and cancer

Published: April 01, 2015

Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 08, 2014

Targeting angiogenic pathway for chemoprevention of experimental colon cancer using C-phycocyanin as cyclooxygenase-2 inhibitor.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: May 28, 2014

The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 24, 2014

Anti-proliferative action of silibinin on human colon adenomatous cancer HT-29 cells.

Journal: Nutricion hospitalaria

Published: February 18, 2014

Piroxicam and c-phycocyanin prevent colon carcinogenesis by inhibition of membrane fluidity and canonical Wnt/β-catenin signaling while up-regulating ligand dependent transcription factor PPARγ.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 23, 2014